ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in Atlanta, GA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Coronavirus Infections
Infections
Post-Acute COVID-19 Syndrome
Human Influenza
Pneumonia
Respiratory Tract Infections
Virus Diseases

COVID-19 trials near Atlanta, GA, USA:

A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations

The purpose of this study is to evaluate the immunogenicity and safety of the recommended variant-containing formulations of mRNA-1283 COVID-...

Enrolling
COVID-19
Biological: mRNA-1283.251 Variant-containing Formulation

Phase 4

Moderna
Moderna

Atlanta, Georgia, United States and 4 other locations

The purpose of this trial is to assess the safety and relative efficacy of CVXGA (CVXGA50), a KP.2 containing vaccine, compared to COMIRNATY® (COVID...

Active, not recruiting
COVID-19
Biological: CVXGA (CVXGA50)
Biological: COMIRNATY®

Phase 2

Cyanvac

Lilburn, Georgia, United States and 54 other locations

Performance of the LumiraDx SARS-CoV-2 Ag assay will be assessed by comparison to a reference method.

Active, not recruiting
Covid19
Diagnostic Test: Fingerstick
Diagnostic Test: Saliva specimen
LumiraDx

Atlanta, Georgia, United States and 6 other locations

The purpose of this study is to investigate the immunogenicity and safety of mRNA COVID-19 variant-containing vaccine formulations ...

Enrolling
SARS-CoV-2
Biological: mRNA-1273 Variant-containing Formulation

Phase 4

Moderna
Moderna

Atlanta, Georgia, United States and 5 other locations

vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID-19).In order to represent a more recently circulating SAR...

Active, not recruiting
COVID-19
SARS-CoV2
Biological: VXA-CoV2-3.1
Biological: VXA-CoV2-3.3

Phase 2

Vaxart

Lilburn, Georgia, United States and 144 other locations

Status recently updated

This is a Phase 4, post-market US study, evaluating the efficacy and safety of a single dose of the NVX-CoV2705 Omicron JN.1 COVID-19...

Not yet enrolling
Active, not recruiting
COVID-19
Sars-CoV-2 Infection
Biological: NVX-CoV2705
Biological: Placebo

Phase 4

Novavax
Novavax

Atlanta, Georgia, United States and 98 other locations

Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most oft-...

Enrolling
Coronavirus Disease (COVID-19)
Drug: Placebo
Drug: Molnupiravir

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Union City, Georgia, United States and 221 other locations

study treatment works in the study) of the study medicine (called nirmatrelvir/ritonavir) for potential treatment of coronavirus disease 2019 (COVID...

Enrolling
COVID-19
Drug: nirmatrelvir
Drug: ritonavir

Phase 3

Pfizer
Pfizer

Atlanta, Georgia, United States and 75 other locations

studies or substudies based on age group and prior history of COVID-19 vaccinations. All participants in each of the 5 sub-studies ...

Active, not recruiting
COVID-19
SARS-CoV-2 Virus
Biological: Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 10 microgram dose
Biological: Variant-adapted BNT162b2 (Omicron XBB.1.5) 10 microgram dose

Phase 3

BioNTech
BioNTech

Atlanta, Georgia, United States and 100 other locations

Status recently updated

The purpose of this study is to learn about the safety and effects of the vaccine (called COMIRNATY) for the potential prevention of COVID-19...

Enrolling
Active, not recruiting
Myocarditis
Diagnostic Test: Cardiac Imaging

Phase 4

Pfizer
Pfizer

Atlanta, Georgia, United States and 17 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems